LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $203,000 | -45.1% | 1,612 | -28.1% | 0.00% | -50.0% |
Q1 2018 | $370,000 | +28.9% | 2,242 | +7.1% | 0.00% | 0.0% |
Q4 2017 | $287,000 | -20.1% | 2,093 | -20.6% | 0.00% | 0.0% |
Q3 2017 | $359,000 | +6.2% | 2,637 | -5.1% | 0.00% | 0.0% |
Q2 2017 | $338,000 | +19.9% | 2,780 | +4.5% | 0.00% | 0.0% |
Q1 2017 | $282,000 | -48.3% | 2,660 | -50.4% | 0.00% | -33.3% |
Q4 2016 | $545,000 | +1.1% | 5,366 | +1.5% | 0.00% | 0.0% |
Q3 2016 | $539,000 | -16.8% | 5,289 | -2.8% | 0.00% | -25.0% |
Q2 2016 | $648,000 | +14.3% | 5,441 | +2.6% | 0.00% | 0.0% |
Q1 2016 | $567,000 | +70.8% | 5,305 | +72.5% | 0.00% | +100.0% |
Q4 2015 | $332,000 | -75.4% | 3,076 | -84.7% | 0.00% | -60.0% |
Q1 2014 | $1,348,000 | – | 20,057 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |